Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: Novel genotypes and phenotypic variability in severe congenital neutropenia

Kaan Boztug, Philip S. Rosenberg, Marie Dorda, Siddharth Banka, Thomas Moulton, Julie Curtin, Nima Rezaei, John Corns, Jeffrey W. Innis, Zekai Avci, Hung Chi Tran, Isabelle Pellier, Paolo Pierani, Rachel Fruge, Nima Parvaneh, Setareh Mamishi, Rajen Mody, Phil Darbyshire, Jayashree Motwani, Jennie MurrayGeorge R. Buchanan, William G. Newman, Blanche P. Alter, Laurence A. Boxer, Jean Donadieu, Karl Welte, Christoph Klein

Research output: Contribution to journalArticle

Abstract

Objective: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe congenital neutropenia (SCN) due to mutations in the gene encoding glucose-6-phosphatase catalytic subunit 3 (G6PC3). Study design: Patients with syndromic SCN were characterized for associated malformations and referred to us for G6PC3 mutational analysis. Results: In a cohort of 31 patients with syndromic SCN, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations. We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3. Additionally, we demonstrate genetic variability in this disease and define novel features such as growth hormone deficiency, genital malformations, disrupted bone remodeling, and abnormalities of the integument. G6PC3 mutations may be associated with hydronephrosis or facial dysmorphism. The risk of transition to myelodysplastic syndrome/acute myeloid leukemia may be lower than in other genetically defined SCN subgroups. Conclusions: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN.

Original languageEnglish (US)
JournalJournal of Pediatrics
Volume160
Issue number4
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Glucose-6-Phosphatase
Catalytic Domain
Genotype
Mutation
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Neutropenia, Severe Congenital, Autosomal Recessive 3
Hydronephrosis
Bone Remodeling
Growth Hormone

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency : Novel genotypes and phenotypic variability in severe congenital neutropenia. / Boztug, Kaan; Rosenberg, Philip S.; Dorda, Marie; Banka, Siddharth; Moulton, Thomas; Curtin, Julie; Rezaei, Nima; Corns, John; Innis, Jeffrey W.; Avci, Zekai; Tran, Hung Chi; Pellier, Isabelle; Pierani, Paolo; Fruge, Rachel; Parvaneh, Nima; Mamishi, Setareh; Mody, Rajen; Darbyshire, Phil; Motwani, Jayashree; Murray, Jennie; Buchanan, George R.; Newman, William G.; Alter, Blanche P.; Boxer, Laurence A.; Donadieu, Jean; Welte, Karl; Klein, Christoph.

In: Journal of Pediatrics, Vol. 160, No. 4, 04.2012.

Research output: Contribution to journalArticle

Boztug, K, Rosenberg, PS, Dorda, M, Banka, S, Moulton, T, Curtin, J, Rezaei, N, Corns, J, Innis, JW, Avci, Z, Tran, HC, Pellier, I, Pierani, P, Fruge, R, Parvaneh, N, Mamishi, S, Mody, R, Darbyshire, P, Motwani, J, Murray, J, Buchanan, GR, Newman, WG, Alter, BP, Boxer, LA, Donadieu, J, Welte, K & Klein, C 2012, 'Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: Novel genotypes and phenotypic variability in severe congenital neutropenia', Journal of Pediatrics, vol. 160, no. 4. https://doi.org/10.1016/j.jpeds.2011.09.019
Boztug, Kaan ; Rosenberg, Philip S. ; Dorda, Marie ; Banka, Siddharth ; Moulton, Thomas ; Curtin, Julie ; Rezaei, Nima ; Corns, John ; Innis, Jeffrey W. ; Avci, Zekai ; Tran, Hung Chi ; Pellier, Isabelle ; Pierani, Paolo ; Fruge, Rachel ; Parvaneh, Nima ; Mamishi, Setareh ; Mody, Rajen ; Darbyshire, Phil ; Motwani, Jayashree ; Murray, Jennie ; Buchanan, George R. ; Newman, William G. ; Alter, Blanche P. ; Boxer, Laurence A. ; Donadieu, Jean ; Welte, Karl ; Klein, Christoph. / Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency : Novel genotypes and phenotypic variability in severe congenital neutropenia. In: Journal of Pediatrics. 2012 ; Vol. 160, No. 4.
@article{4efa413bebdd4a0f8886080b69aab3b4,
title = "Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: Novel genotypes and phenotypic variability in severe congenital neutropenia",
abstract = "Objective: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe congenital neutropenia (SCN) due to mutations in the gene encoding glucose-6-phosphatase catalytic subunit 3 (G6PC3). Study design: Patients with syndromic SCN were characterized for associated malformations and referred to us for G6PC3 mutational analysis. Results: In a cohort of 31 patients with syndromic SCN, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations. We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3. Additionally, we demonstrate genetic variability in this disease and define novel features such as growth hormone deficiency, genital malformations, disrupted bone remodeling, and abnormalities of the integument. G6PC3 mutations may be associated with hydronephrosis or facial dysmorphism. The risk of transition to myelodysplastic syndrome/acute myeloid leukemia may be lower than in other genetically defined SCN subgroups. Conclusions: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN.",
author = "Kaan Boztug and Rosenberg, {Philip S.} and Marie Dorda and Siddharth Banka and Thomas Moulton and Julie Curtin and Nima Rezaei and John Corns and Innis, {Jeffrey W.} and Zekai Avci and Tran, {Hung Chi} and Isabelle Pellier and Paolo Pierani and Rachel Fruge and Nima Parvaneh and Setareh Mamishi and Rajen Mody and Phil Darbyshire and Jayashree Motwani and Jennie Murray and Buchanan, {George R.} and Newman, {William G.} and Alter, {Blanche P.} and Boxer, {Laurence A.} and Jean Donadieu and Karl Welte and Christoph Klein",
year = "2012",
month = "4",
doi = "10.1016/j.jpeds.2011.09.019",
language = "English (US)",
volume = "160",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency

T2 - Novel genotypes and phenotypic variability in severe congenital neutropenia

AU - Boztug, Kaan

AU - Rosenberg, Philip S.

AU - Dorda, Marie

AU - Banka, Siddharth

AU - Moulton, Thomas

AU - Curtin, Julie

AU - Rezaei, Nima

AU - Corns, John

AU - Innis, Jeffrey W.

AU - Avci, Zekai

AU - Tran, Hung Chi

AU - Pellier, Isabelle

AU - Pierani, Paolo

AU - Fruge, Rachel

AU - Parvaneh, Nima

AU - Mamishi, Setareh

AU - Mody, Rajen

AU - Darbyshire, Phil

AU - Motwani, Jayashree

AU - Murray, Jennie

AU - Buchanan, George R.

AU - Newman, William G.

AU - Alter, Blanche P.

AU - Boxer, Laurence A.

AU - Donadieu, Jean

AU - Welte, Karl

AU - Klein, Christoph

PY - 2012/4

Y1 - 2012/4

N2 - Objective: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe congenital neutropenia (SCN) due to mutations in the gene encoding glucose-6-phosphatase catalytic subunit 3 (G6PC3). Study design: Patients with syndromic SCN were characterized for associated malformations and referred to us for G6PC3 mutational analysis. Results: In a cohort of 31 patients with syndromic SCN, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations. We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3. Additionally, we demonstrate genetic variability in this disease and define novel features such as growth hormone deficiency, genital malformations, disrupted bone remodeling, and abnormalities of the integument. G6PC3 mutations may be associated with hydronephrosis or facial dysmorphism. The risk of transition to myelodysplastic syndrome/acute myeloid leukemia may be lower than in other genetically defined SCN subgroups. Conclusions: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN.

AB - Objective: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe congenital neutropenia (SCN) due to mutations in the gene encoding glucose-6-phosphatase catalytic subunit 3 (G6PC3). Study design: Patients with syndromic SCN were characterized for associated malformations and referred to us for G6PC3 mutational analysis. Results: In a cohort of 31 patients with syndromic SCN, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations. We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3. Additionally, we demonstrate genetic variability in this disease and define novel features such as growth hormone deficiency, genital malformations, disrupted bone remodeling, and abnormalities of the integument. G6PC3 mutations may be associated with hydronephrosis or facial dysmorphism. The risk of transition to myelodysplastic syndrome/acute myeloid leukemia may be lower than in other genetically defined SCN subgroups. Conclusions: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN.

UR - http://www.scopus.com/inward/record.url?scp=84858335877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858335877&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2011.09.019

DO - 10.1016/j.jpeds.2011.09.019

M3 - Article

C2 - 22050868

AN - SCOPUS:84858335877

VL - 160

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 4

ER -